Alexander James Fay MD PhD
Neuromuscular Medicine, Child Neurology
Associate Professor
Request Appointment
Department if Neurology1825 4th Street, 5th Floor, 5ASan Francisco, CA 94143
Fax+1 415-353-2400
Overview of Dr. Fay
Dr. Alexander Fay is a neurologist in San Francisco, CA and is affiliated with multiple hospitals in the area, including UCSF Medical Center and UCSF Benioff Children's Hospital Oakland. He received his medical degree from University of California San Francisco School of Medicine and has been in practice 16 years. He is one of 328 doctors at UCSF Medical Center and one of 13 doctors at UCSF Benioff Children's Hospital Oakland who specialize in Neurology. He has more than 10 publications and over 500 citings.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Child Neurology, 2012 - 2015- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 2010 - 2012
University of California San Francisco School of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2016 - 2028
MO State Medical License 2015 - 2017
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2017
Publications & Presentations
PubMed
- Psychometric properties of the Infantile Neuroaxonal Dystrophy Rating Scale.Alessandra Girardi, Linda Abetz-Webb, Katja Rudell, Paldeep S Atwal, Alexander Fay
Developmental Medicine and Child Neurology. 2026-05-01 - 3 citationsUrine-Acetylaspartate Distinguishes Phenotypes in Canavan Disease.Amanda Nagy, Florian Eichler, Annette Bley, Janna Bredow, Alexander Fay
Human Gene Therapy. 2024-01-01 - Andersen-Tawil syndrome.Jill A Goslinga, Louis J PtáČek, Rabi Tawil, Alexander Fay
Handbook of Clinical Neurology. 2024-01-01
Press Mentions
Roche’s SMA Therapy Faces Uphill Struggle Against SpinrazaAugust 6th, 2019
Muscular Dystrophy Association Celebrates FDA Approval of Argenx’s Vyvgart Hytrulo Injection for Treatment of Generalized Myasthenia GravisJune 22nd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
